(Q40581747)

21 September 2017

title

Ten-year survival in women with primary stage IV breast cancer (English)

1 reference

21 September 2017

9

Steven A Narod

1 reference

21 September 2017

Lee Guek Eng

1

1 reference

21 September 2017

Shaheenah Dawood

2

1 reference

21 September 2017

Victoria Sopik

3

1 reference

21 September 2017

Benjamin Haaland

4

1 reference

21 September 2017

Pui San Tan

5

1 reference

21 September 2017

Nirmala Bhoo-Pathy

6

1 reference

21 September 2017

Ellen Warner

7

1 reference

21 September 2017

Javaid Iqbal

8

1 reference

21 September 2017

Rebecca Dent

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

14 September 2016

1 reference

Breast Cancer Research and Treatment

21 September 2017

published in

1 reference

21 September 2017

volume

160

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

145-152

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-016-3974-x

21 September 2017

exact match

0 references

cites work

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

The relation between survival and age at diagnosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Young age: an independent risk factor for disease-free survival in women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

C-erbB-2 overexpression and survival in early onset breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Survival differences among women with de novo stage IV and relapsed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

The effect of comorbidity on 3-year survival of women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3974-X

10.1007/S10549-016-3974-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1029473584

0 references

1 reference